Home | Welcome to Contract Pharma   
Last Updated Friday, July 11 2014
Print RSS Feed

Search Results for 'contractpharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

News
Published February 28, 2011
Find the latest news and trends related to outsourcing and contract services for pharma and biopharma by clicking on specific news categories below. Read More »
Contract Pharma Team
Published February 28, 2011
Contract Pharma Team President, Rodman J. Zilenziger, Jr. Rodman J. Zilenziger Jr. — President of Rodman Media since 1993. Zilenziger, son of the Company’s founder, joined Rodman Media as an Advertising Representa… Read More »
By Michael Sauter, Director, Business Development
Published October 28, 2013
Adds 1000L HyClone SUB Read More »
Metrics, Inc.
By Jeff Basham, VP, Business Development
Metrics Inc. is one of the most respected CDMOs in the United States. Offering first-time-in-man (FTIM) development, and Phase I, II and III clinical trial material, Metrics has conducted more than 75 FTIM studies for different entities in the past f… Read More »
Published July 17, 2012
Fill out my online form. var r7x2s9;(function(d, t) { var s = d.createElement(t), options = { 'userName':'rodmanpublishing', 'formHash':'r7x2s9', 'autoResize':true, 'height':'577', 'async':true, 'header':'show'}; s.src = ('https:' == d.location.p… Read More »
2012 - Thirteenth Annual Salary Survey
By Gil Roth, Editor
Published June 19, 2012
Welcome to Contract Pharma’s Thirteenth Annual Salary Survey! This year’s results are derived from nearly 650 respondents from our readership about employment attitudes, responsibilities, education, and their 2011 salaries. Read More »
U.S. CMO Market Report
By Jesse Sullivan and Jennifer Brice, Frost & Sullivan
Published May 30, 2012
A growth industry in transition Read More »
By Andreas Scherer, Ph.D.
Published March 21, 2012
Holy Grail or Buying Time? Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On